Skip to content

Effect of adenosine A2a receptor blockade on dopamine D2 receptors

Effect of adenosine 2a antagonist on striatal dopamine D2 receptors - STA2AD2 study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031180131
Enrollment
40
Registered
2019-02-18
Start date
2019-05-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physically and mentally healthy

Interventions

Sponsors

Okita Kyoji
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Physically and mentally healthy male nonsmokers aged between 20 and 65 (nonsmoker is defined as those who has not smoked for the last one year) 2.No problems with communication in Japanese language and understanding documents of informed consent

Exclusion criteria

Exclusion criteria: 1.Past history of neurological and/or psychiatric disorders 2.Intracranial lesion(s) seen in MRI 3.Impairment of liver and/or renal function 4.HIV seropositive 5.Positive urine-sample test for illegal drug 6.Past history of suicidal ideation or attempt 7.Claustrophobia or aichmophobia 8.MRI imcompatible metals inside the body 9.Use of psychotropic drugs which could have an impact on dopamine D2 receptor availability 10.Engaged in night work 11.Employees of National Center of Neurology and Psychiatry or any companies that have a business connection with National Center of Neurology and Psychiatry 12.Participate in any other clinical trials or studies 13.In case of principle investigator judges inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Striatal dopamine D2 receptor availability

Secondary

MeasureTime frame
Neurocognitive measures relating impulsivity, eyelid movement (eyeblinks) and plasma concentration of istradefylline

Contacts

Public ContactKaori Takeda

National Center of Neurology and Psychiatry

kortakeda@ncnp.go.jp+81-42-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026